Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rudy Scheldewaert"'
Publikováno v:
Arzneimittelforschung. 49:311-317
The use of beta-blockers in heart failure for a long time was regarded as contra-indicated because of their negative inotropic effects. Nevertheless, there is growing evidence that beta-blockers slow down the progression of left ventricular dilatatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9122a94cb4a0ae5e89c43d6088f847a
https://doi.org/10.1055/s-0031-1300420
https://doi.org/10.1055/s-0031-1300420
Autor:
Jean-P Santoni, Rudy Scheldewaert, Ian R. Starkey, Michel E. Bertrand, William E. Boden, Wiek H. van Gilst, Anne Whitehead, K.I. Lie, Ole Lederballe Pedersen, Jacques Col, Desmond G. Julian, Marc Carlier, Kim Fox
Publikováno v:
Scopus-Elsevier
LANCET, 355(9217), 1751-1756. ELSEVIER SCIENCE INC
LANCET, 355(9217), 1751-1756. ELSEVIER SCIENCE INC
Background Diltiazem reduces non-fatal reinfarction and refractory ischaemia after non-Q-wave myocardial infarction, an acute coronary syndrome similar to the incomplete infarction that occurs after successful reperfusion. We postulated that this age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbf4c3ef17bccaa07fcdb6bacc420d4
https://doi.org/10.1016/s0140-6736(00)02262-5
https://doi.org/10.1016/s0140-6736(00)02262-5
Autor:
Jean-Philippe Santoni, Rudy Scheldewaert, Graham Belgrave, Ewan G. Walters, William E. Boden, Anne Whitehead, D. John Coltart, Ian R. Starkey
Publikováno v:
The American Journal of Cardiology. 75:1120-1123
Several pharmacologic forms of adjunctive therapy, designed to enhance the efficacy of thrombolysis following acute myocardial infarction (AMI), are being explored. However, few studies have assessed the use of standard secondary prevention therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a40c924d7c0a0c52909d2fe996853d0
https://doi.org/10.1016/s0002-9149(99)80742-5
https://doi.org/10.1016/s0002-9149(99)80742-5
Autor:
Philippe Unger, Rudy Scheldewaert, Zhen Ying Fang, Guy Berkenboom, Nelly Picart, Marc Abramowicz, Serge Degré, John Sobolski, Pascale Narracci
Publikováno v:
The American Journal of Cardiology. 68:42-46
For 18 patients consecutively admitted to the coronary care unit for unstable angina, 48-hour electrocardiographic Holter monitoring was performed after they were randomly assigned in a single-blind fashion to 1 of 2 treatment groups. The first group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f59bfcc653c7d418cb561e43bd60dc0
https://doi.org/10.1016/0002-9149(91)90222-7
https://doi.org/10.1016/0002-9149(91)90222-7
Publikováno v:
Clinical cardiology. 24(1)
Background: Epidemiologic evidence suggests that an elevated heart rate (HR) is an adverse and independent prognostic factor in arterial hypertension and other cardiovascular diseases. Although diltiazem is characterized as an HR-lowering calcium ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46bb8d40bbba51f1aa03206461e486d5
https://pubmed.ncbi.nlm.nih.gov/11195610
https://pubmed.ncbi.nlm.nih.gov/11195610